异步性与病理性种植窗:复发性种植失败的两个原因
该回顾性分析比较对照组(n=72)与复发性种植失败(RIF)患者(n=43)的种植窗子宫内膜转录组学预测,发现RIF存在种植窗移位和种植窗病理破坏两种原因,二者可独立或同时出现,并提出新的转录组学RIF分类。
要点
- RIF存在种植窗移位与病理破坏两种分子原因,可独立或并存。
- RIF患者转录组分层:仅移位18.6%、移位伴病理53.5%、仅病理破坏23.3%、非子宫内膜来源4.7%。
- 69%的签名预测准确率高于随机预期,范围0.87至0.97。
核心结论
- 预测结果表明,移位和破坏的种植窗均存在,且可在同一RIF患者中独立或同时出现。
- RIF患者按临床标准定义后,转录组分层为18.6%仅移位种植窗、53.5%移位伴病理种植窗、23.3%仅破坏种植窗、4.7%可能为临床RIF但非子宫内膜来源。
研究设计与样本
- 回顾性分析,比较对照组(n=72)与RIF患者(n=43)的种植窗子宫内膜转录组学预测。
- RIF临床定义为四次或以上高质量胚胎移植后或多次移植中放置10个或以上胚胎后未着床。
- 子宫内膜组织样本采集于LH+5至LH+8。
- 利用115个基因表达谱,开发两种预测设计:一种去除月经周期时间比较RIF与对照(破坏或病理模型),另一种按时间分层种植窗转录组谱以预测移位。
主要发现
- 从分析的16个签名中,明确预测了RIF的两种原因:移位种植窗和准时但病理破坏的种植窗。
- 大多数签名中发现了与月经周期时间相关的种植窗谱高预测价值;具体而言,69%的分析签名在0.87至0.97范围内呈现高于随机预期的准确率。
- 移位和破坏在分子上并非独立,部分签名与两种原因均中度相关。
- 签名间基因和功能比较显示并不相似,但发现共同功能及部分预测移位的签名间存在中度功能一致性聚类(最高Cohen's Kappa指数在0.55至0.62之间,取决于功能数据库)。
关键数值与推荐
- RIF患者转录组分层:仅移位种植窗18.6%、移位伴病理种植窗53.5%、仅破坏种植窗23.3%、可能非子宫内膜来源的临床RIF 4.7%。
- 69%的分析签名预测准确率高于随机预期,范围为0.87至0.97。
- 预测移位的签名间最高Cohen's Kappa指数在0.55至0.62之间,取决于功能数据库。
临床怎么用
- 作者提出新的转录组学RIF分类,以填补先前研究间的空白,并建立临床实践中检测和区分两种RIF的方法。
- 作者认为,理解如何对RIF患者分类以临床区分可能从个性化胚胎移植日获益的患者与种植窗破坏的患者,将有助于识别和分层以研究与开发新治疗。
局限性
- 每个签名的绝对预测值在这些预测设计中并不具有指示性;相反,签名间的比较对于同一样本队列中两种RIF原因的预测能力最为重要。
- 本研究未分析所提出RIF分类的临床随访,因此需要进一步的前瞻性临床研究以确定这些表型的患病率和外显率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is endometrial recurrent implantation failure (RIF) only a matter of an asynchronous (displaced) window of implantation (WOI), or could it also be a pathological (disrupted) WOI? SUMMARY ANSWER: Our predictive results demonstrate that both displaced and disrupted WOIs exist and can present independently or together in the same RIF patient. WHAT IS KNOWN ALREADY: Since 2002, many gene expression signatures associated with endometrial receptivity and RIF have been described. Endometrial transcriptomics prediction has been applied to the human WOI in two previous studies. One study describes endometrial RIF to be the result of a temporal displacement of the WOI. The other indicates that endometrial RIF can also result from a molecularly disrupted WOI without temporal displacement. STUDY DESIGN, SIZE, DURATION: Retrospective analysis was undertaken to compare WOI endometrial transcriptomics predictions in controls (n = 72) and RIF patients (n = 43). RIF was clinically designated by the absence of implantation after four or more transfers of high quality embryos or after the placement of 10 or more embryos in multiple transfers. Endometrial tissue samples were collected from LH + 5 to LH + 8. We compared the two molecular causes of RIF to signatures currently described in the literature. We propose a new transcriptomic RIF taxonomy to fill the gap between the two hypotheses and to guide the development of clinical detection and determination of both types of RIF. PARTICIPANTS/MATERIALS, SETTING, METHODS: Utilizing 115 gene expression profiles, two different predictive designs were developed: one considering RIF versus controls removing menstrual cycle timing, called the disrupted or pathological model, and another stratifying the WOI in transcriptomic profiles related to timing for predicting displacements. The predictive value of each model was compared between all signatures selected. We propose a new genomic approach that distinguishes between both types of RIF in the same sample cohort. MAIN RESULTS AND THE ROLE OF CHANCE: From the 16 signatures analysed, we clearly predicted two causes of RIF-both a displaced WOI and an on-time but pathologically disrupted WOI. A high predictive value related to WOI profiles associated with menstrual cycle timing was found in most of the signatures. Specifically, 69% of the signatures analysed presented an accuracy higher than expected by chance in a range from 0.87 to 0.97. Displacements and disruptions were not molecularly independent, as some signatures were moderately associated with both causes. The gene and functional comparison between signatures revealed that they were not similar, although we did find functions in common and a cluster of moderate functional concordance between some of the signatures that predicted displacements (the highest Cohen's Kappa index were between 0.55 and 0.62 depending on the functional database). We propose a new transcriptomic RIF taxonomy to fill the gap between these prior studies and to establish methodology for detecting and distinguishing both types of RIF in clinical practice. Our findings indicate these two phenotypes could present independently or together in the same RIF patient. RIF patients designated by clinical criteria have been stratified transcriptomically as 18.6% with only a displaced WOI, 53.5% with a displaced and pathological WOI, 23.3% with only a disrupted WOI, and 4.7% could be a clinical RIF with non-endometrial origin. The new RIF transcriptomic taxonomy avoids menstrual cycle timing as a confounding variable that should be controlled for, distinguishing clearly between a disrupted and a displaced WOI for precision medicine in RIF. LIMITATIONS REASONS FOR CAUTION: The main objective of this study was to use transcriptomics to detect both RIF causes and to understand the role of transcriptomic signatures in these phenotypes. The predictive value in absolute terms for each signature was not indicative in these prediction designs; instead, the comparison between signatures was most important for prediction capability in the same sample cohort for both RIF causes. Clinical follow up of the RIF taxonomies proposed has not been analysed in this study, so further prospective clinical studies are necessary to determine the prevalence and penetrance of these phenotypes. WIDER IMPLICATIONS OF THE FINDINGS: The main insight from this study is a new understanding of RIF taxonomy. Understanding how to classify RIF patients to distinguish clinically between a patient who could benefit from a personalized embryo transfer day and a patient with a disrupted WOI will enable identification and stratification for the research and development of new treatments. In addition, we demonstrate that basic research designs in endometrial transcriptomics cause masking of the study variable by the menstrual cycle timing. STUDY FUNDING/COMPETING INTEREST(S): This research has been funded by IVI-RMA; the authors do not have any competing interests.
引用
- Sebastian-Leon P, Garrido N, Remohí J, et al. Asynchronous and pathological windows of implantation: two causes of recurrent implantation failure. Hum Reprod. 2018. PMID: 29452422. doi:10.1093/humrep/dey023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。